- Home
- GPCR vs BDJ Comparison
GPCR vs BDJ Comparison
Compare GPCR & BDJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- BDJ
- Stock Information
- Founded
- GPCR 2016
- BDJ 2005
- Country
- GPCR United States
- BDJ United States
- Employees
- GPCR N/A
- BDJ N/A
- Industry
- GPCR
- BDJ Finance Companies
- Sector
- GPCR
- BDJ Finance
- Exchange
- GPCR Nasdaq
- BDJ Nasdaq
- Market Cap
- GPCR 1.8B
- BDJ 1.6B
- IPO Year
- GPCR 2023
- BDJ N/A
- Fundamental
- Price
- GPCR $27.03
- BDJ $8.33
- Analyst Decision
- GPCR Buy
- BDJ
- Analyst Count
- GPCR 6
- BDJ 0
- Target Price
- GPCR $85.67
- BDJ N/A
- AVG Volume (30 Days)
- GPCR 797.2K
- BDJ 561.6K
- Earning Date
- GPCR 11-13-2024
- BDJ 01-01-0001
- Dividend Yield
- GPCR N/A
- BDJ 8.85%
- EPS Growth
- GPCR N/A
- BDJ N/A
- EPS
- GPCR N/A
- BDJ N/A
- Revenue
- GPCR N/A
- BDJ N/A
- Revenue This Year
- GPCR N/A
- BDJ N/A
- Revenue Next Year
- GPCR N/A
- BDJ N/A
- P/E Ratio
- GPCR N/A
- BDJ N/A
- Revenue Growth
- GPCR N/A
- BDJ N/A
- 52 Week Low
- GPCR $29.48
- BDJ $6.91
- 52 Week High
- GPCR $62.74
- BDJ $8.66
- Technical
- Relative Strength Index (RSI)
- GPCR 35.94
- BDJ 25.80
- Support Level
- GPCR $30.81
- BDJ $8.83
- Resistance Level
- GPCR $36.42
- BDJ $8.71
- Average True Range (ATR)
- GPCR 2.10
- BDJ 0.10
- MACD
- GPCR -0.15
- BDJ -0.06
- Stochastic Oscillator
- GPCR 25.07
- BDJ 4.38
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About BDJ Blackrock Enhanced Equity Dividend Trust
BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.